Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

96.77
-5.6700-5.53%
Post-market: 96.77-0.00400.00%19:30 EDT
Volume:914.28K
Turnover:88.83M
Market Cap:6.66B
PE:-31.04
High:101.66
Open:101.66
Low:96.14
Close:102.44
52wk High:122.20
52wk Low:74.50
Shares:68.85M
Float Shares:65.39M
Volume Ratio:1.64
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1172
EPS(LYR):-3.1100
ROE:-117.04%
ROA:-30.96%
PB:64.70
PE(LYR):-31.12

Loading ...

Rhythm Pharmaceuticals Announces Imcivree® (Setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity Due to Hypothalamic Injury or Impairment

THOMSON REUTERS
·
Aug 11

Rhythm Pharmaceuticals Price Target Raised to $146.00/Share from $145.00 by JP Morgan

Dow Jones
·
Aug 08

How Investors May Respond To Rhythm Pharmaceuticals (RYTM) Q2 Results And Early RM-718 Obesity Data

Simply Wall St.
·
Aug 07

Rhythm Pharmaceuticals is Maintained at Market Outperform by Citizens

Dow Jones
·
Aug 05

RBC Adjusts Price Target on Rhythm Pharmaceuticals to $155 From $141, Maintains Outperform Rating

MT Newswires Live
·
Aug 05

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Rhythm Pharmaceuticals price target raised to $160 from $155 at Citizens

TIPRANKS
·
Aug 05

Sweden's Xspray Posts Narrow Q2 Pretax Loss as Costs Fall

Reuters
·
Aug 05

Ultragenyx Q2 Revenue Rises 28% to Record High, Net Loss Narrows

Reuters
·
Aug 05

Travere Therapeutics Q2 Product Sales Rise on Filspari Demand

Reuters
·
Aug 05

Precigen Posts Quarterly Profit as Papzimeos Sales Surge

Reuters
·
Aug 05

Spyre Therapeutics Q2 Loss Narrower than Expected; Sees Trial Readouts in 2026

Reuters
·
Aug 05

Rigel Pharmaceuticals Q2 Revenue Rises on Strong Product Demand

Reuters
·
Aug 05

Arrowhead Pharmaceuticals Q3 Revenue Jumps on Redemplo Growth

Reuters
·
Aug 05

Rhythm Pharma Executives to Speak at Canaccord Genuity Growth Conference Fireside Chat

Reuters
·
Aug 05

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 05

Rhythm Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Rhythm Pharma's Obesity Drug Shows Promise for Brain Tumor-Related Weight Condition

Reuters
·
Aug 04

Palvella Therapeutics Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 04

Stock Track | Rhythm Pharmaceuticals Soars 5.58% in Pre-market on Q2 Earnings Beat and Positive Phase 2 RM-718 Data

Stock Track
·
Aug 04